COVID-19 Pandemic: Cardiovascular Complications and Future Implications

被引:84
作者
Bandyopadhyay, Dhrubajyoti [1 ]
Akhtar, Tauseef [2 ]
Hajra, Adrija [3 ]
Gupta, Manasvi [4 ]
Das, Avash [5 ]
Chakraborty, Sandipan [6 ]
Pal, Ipsita [7 ]
Patel, Neelkumar [8 ]
Amgai, Birendra [8 ]
Ghosh, Raktim K. [9 ]
Fonarow, Gregg C. [10 ]
Lavie, Carl J. [11 ]
Naidu, Srihari S. [12 ]
机构
[1] Mt Sinai St Lukes Roosevelt Hosp, Icahn Sch Med Mt Sinai, New York, NY USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA
[4] Univ Connecticut, Sch Med, Hartford, CT 06112 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[6] Miami Valley Hosp, Columbus, OH USA
[7] Columbia Univ, Irving Med Ctr, New York, NY USA
[8] Interfaith Med Ctr, Brooklyn, NY USA
[9] Medstar Union Mem Hosp, Baltimore, MD USA
[10] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
[11] Univ Queensland, Sch Med, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, New Orleans, LA USA
[12] Westchester Med Ctr, Valhalla, NY USA
基金
美国国家卫生研究院;
关键词
CORONAVIRUS DISEASE 2019; CORONARY-HEART-DISEASE; AVASCULAR NECROSIS; CHRONIC-FATIGUE; CYTOKINE STORM; WUHAN; PNEUMONIA; MORTALITY; OUTCOMES; INJURY;
D O I
10.1007/s40256-020-00420-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a global pandemic with the highest number of affected individuals in the modern era. Not only is the infection inflicting significant morbidity and mortality, but there has also been a significant strain to the health care system and the economy. COVID-19 typically presents as viral pneumonia, occasionally leading to acute respiratory distress syndrome (ARDS) and death. However, emerging evidence suggests that it has a significant impact on the cardiovascular (CV) system by direct myocardial damage, severe systemic inflammatory response, hypoxia, right heart strain secondary to ARDS and lung injury, and plaque rupture secondary to inflammation. Primary cardiac manifestations include acute myocarditis, myocardial infarction, arrhythmia, and abnormal clotting. Several consensus documents have been released to help manage CV disease during this pandemic. In this review, we summarize key cardiac manifestations, their management, and future implications.
引用
收藏
页码:311 / 324
页数:14
相关论文
共 107 条
  • [1] Remdesivir as a possible therapeutic option for the COVID-19
    Al-Tawfiq, Jaffar A.
    Al-Homoud, Ali H.
    Memish, Ziad A.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 34
  • [2] American College of Cardiology, VENTR ARRH RISK DUE VENTR ARRH RISK DUE
  • [3] Potential of heparin and nafamostat combination therapy for COVID-19
    Asakura, Hidesaku
    Ogawa, Haruhiko
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1521 - 1522
  • [4] Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome
    Bajwa, Ednan K.
    Boyce, Paul D.
    Januzzi, James L.
    Gong, Michelle N.
    Thompson, B. Taylor
    Christiani, David C.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (11) : 2484 - 2490
  • [5] Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
    Baldi, Enrico
    Mare, Claudio
    Savastano, Simone
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) : 496 - 498
  • [6] Cardiovascular implications of Zika virus infection
    Bandyopadhyay, Dhrubajyoti
    Ashish, Kumar
    Ghosh, Sudeshna
    Hajra, Adrija
    Modi, Vivek Amit
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 52 : E35 - E36
  • [7] Antisense oligonucleotide targeting of thrombopoietin represents a novel platelet depletion method to assess the immunomodulatory role of platelets
    Barrett, Tessa J.
    Wu, Benjamin G.
    Revenko, Alexey S.
    MacLeod, A. Robert
    Segal, Leopoldo N.
    Berger, Jeffrey S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (07) : 1773 - 1782
  • [8] Natural regulatory T cells in infectious disease
    Belkaid, Y
    Rouse, BT
    [J]. NATURE IMMUNOLOGY, 2005, 6 (04) : 353 - 360
  • [9] Belohlávek J, 2013, EXP CLIN CARDIOL, V18, P129
  • [10] Cardiovascular characteristics of chronic fatigue syndrome
    Bozzini, Sara
    Albergati, Andrea
    Capelli, Enrica
    Lorusso, Lorenzo
    Gazzaruso, Carmine
    Pelissero, Gabriele
    Falcone, Colomba
    [J]. BIOMEDICAL REPORTS, 2018, 8 (01) : 26 - 30